| Entry |
|
|---|
| Name |
Azilsartan (JAN/USAN/INN);
Azilva (TN) |
|---|
| Formula |
C25H20N4O5
|
|---|
| Exact mass |
456.1434
|
|---|
| Mol weight |
456.4501
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Cardiovascular agent
DG01495 Angiotensin II receptor antagonist
DG01925 Renin-angiotensin system inhibitor
DG01495 Angiotensin II receptor antagonist
Metabolizing enzyme substrate
DG01642 CYP2C9 substrate
|
|---|
| Remark |
| Therapeutic category: | 2149 |
| Product (DG00351): | D08864<JP> D08865<US> |
| Product (mixture): | D10524<JP> |
|
|---|
| Efficacy |
Antihypertensive, Angiotensin II receptor antagonist |
|---|
| Comment |
Treatment of hypertension
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04270 | Vascular smooth muscle contraction |
|
|---|
| Metabolism |
Enzyme: CYP2C9 [HSA: 1559]
|
|---|
| Interaction |
|
|---|
| Brite |
USP drug classification [BR:br08302]
Cardiovascular Agents
Angiotensin II Receptor Antagonists
Azilsartan
D08864 Azilsartan (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
214 Antihypertensives
2149 Others
D08864 Azilsartan (JAN/USAN/INN)
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Angiotensin
AGTR1
D08864 Azilsartan (JAN/USAN/INN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D08864
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D08864
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D08864
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 34
1 C8y C 22.2302 -17.2042
2 N4y N 21.8107 -15.8755
3 C8y C 23.6288 -17.2042
4 C8y C 21.5309 -18.3929
5 C8y C 22.9295 -15.0364
6 C1b C 20.6219 -15.1762
7 N5x N 24.1183 -15.8755
8 C8x C 24.3281 -18.3929
9 C8x C 22.2302 -19.5817
10 C6a C 20.8317 -19.5817
11 O2a O 22.9295 -13.6378
12 C8y C 19.3632 -15.8755
13 C8x C 23.6288 -19.5817
14 O6a O 21.5309 -20.8404
15 C1b C 24.1882 -12.9385
16 C8x C 18.1744 -15.2461
17 C8x C 19.3631 -17.2741
18 C1a C 24.1882 -11.5399
19 C8x C 16.9856 -15.9454
20 C8x C 18.2443 -18.0433
21 C8y C 16.9856 -17.3440
22 C8y C 15.7968 -18.0433
23 C8y C 14.5381 -17.4139
24 C8x C 15.7968 -19.4419
25 C8y C 14.5381 -15.9454
26 C8x C 13.4193 -18.1132
27 C8x C 14.6080 -20.2111
28 N4x N 13.4192 -15.1762
29 N5x N 15.6569 -15.1063
30 C8x C 13.4192 -19.5118
31 C8y C 13.8388 -13.8476
32 O7x O 15.2374 -13.8476
33 O6a O 12.9842 -12.7405
34 O6a O 19.4332 -19.5645
BOND 38
1 1 2 1
2 1 3 2
3 1 4 1
4 2 5 1
5 2 6 1
6 3 7 1
7 3 8 1
8 4 9 2
9 4 10 1
10 5 11 1
11 6 12 1
12 8 13 2
13 10 14 2
14 11 15 1
15 12 16 1
16 12 17 2
17 15 18 1
18 16 19 2
19 17 20 1
20 19 21 1
21 21 22 1
22 22 23 1
23 22 24 2
24 23 25 1
25 23 26 2
26 24 27 1
27 25 28 1
28 25 29 2
29 26 30 1
30 28 31 1
31 29 32 1
32 5 7 2
33 9 13 1
34 20 21 2
35 27 30 2
36 31 32 1
37 31 33 2
38 10 34 1
|
|---|
